HighTower Advisors
RVMD icon

HighTower Advisors’s Revolution Medicines RVMD Stock Holding History

HighTower Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
10,485
+7,935
+311% +$1.16M ﹤0.01% 1794
2026
Q1 		$248K Sell
2,550
-199
-7% -$20.1K ﹤0.01% 3323
2025
Q4 		$219K Buy
+2,749
New +$180K ﹤0.01% 3299
2024
Q3 		– Sell
-10,097
Closed -$393K – 3942
2024
Q2 		$393K Buy
+10,097
New +$377K ﹤0.01% 2503
2023
Q4 		– Sell
-10,758
Closed -$297K – 3824
2023
Q3 		$297K Buy
+10,758
New +$319K ﹤0.01% 2609

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

HighTower Advisors's RVMD Position: Q2 2026 in Review

HighTower Advisors increased its Revolution Medicines (RVMD) stake by 311% in Q2 2026, buying an estimated $1.16M and bringing the position to 10,485 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

HighTower Advisors first reported a position in RVMD in Q3 2023 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • HighTower Advisors held 10,485 shares of Revolution Medicines worth $1.96M as of Q2 2026.
  • HighTower Advisors bought 7,935 Revolution Medicines shares in Q2 2026, an estimated $1.16M.
  • Revolution Medicines made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1794 holding.
  • HighTower Advisors first reported a position in Revolution Medicines in Q3 2023 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.